IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Stock Information for Magal Security Systems Ltd.

Loading

Please wait while we load your information from QuoteMedia.